Artiva Biotherapeutics, Inc. Ratios

Ratios Dec2023 Dec2024
Profitability
EBT Margin -85.54%-26,045.02%
EBIT Margin -91.58%-26,805.58%
EBITDA Margin -84.83%-26,219.12%
Operating Margin -91.58%-26,805.58%
Net Margin -85.75%-26,045.02%
FCF Margin -151.34%-22,180.88%
Efficiency
Assets Average 157.35M
Equity Average 12.31M
Invested Capital -162.01M186.64M
Asset Utilization Ratio 0.00
Leverage & Solvency
Equity Ratio -1.540.89
Valuation
Enterprise Value 42.67M59.41M
Market Capitalization 244.84M
Return Ratios
Return on Sales -0.86%-260.45%
Return on Capital Employed -0.46%
Return on Assets -0.42%
Return on Equity -5.31%